President Donald Trump’s tariffs have tanked the markets, but he’s only just getting started. The White House will soon ...

President Donald Trump announced during a speech at the National Republican Congressional Committee dinner on Tuesday that he ...

O ver the last few years, there has been increasing pressure on the U.S. health care system: this includes issues related to ...

Ministers must treat medicines supplies as a ‘defence’ issue as it faces ‘hostile activity’ over the brewing trade war ...

Taxing imports to the US could spell major consequences for health care prices, innovation, and access, as a great amount of ...

Although President Donald Trump’s “Liberation Day” tariffs have spared pharmaceuticals, potential drug-specific import taxes ...

Gene therapy companies have faced numerous setbacks over the last few years. What will it take for gene therapies to fulfill ...

Organoids are made to model human organs and are promising for research and therapy, but there are limitations in their ...

Novo and Lilly have seen skyrocketing global demand for their innovative weight-loss drugs, with investor interest also ...

Introduction Pharma 4.0 refers to the digital transformation of pharmaceutical manufacturing, integrating advanced technologies such as AI, IoT ...

The growing number of Australians with obesity is causing economic damage but should the taxpayer fund weight-loss drugs?

Patients in Scotland can't get the treatment - which is available in England - despite manufacturers giving it away for free ...